HRP20171058T1 - Derivati dipeptida lizinske glutaminske kiseline - Google Patents

Derivati dipeptida lizinske glutaminske kiseline Download PDF

Info

Publication number
HRP20171058T1
HRP20171058T1 HRP20171058TT HRP20171058T HRP20171058T1 HR P20171058 T1 HRP20171058 T1 HR P20171058T1 HR P20171058T T HRP20171058T T HR P20171058TT HR P20171058 T HRP20171058 T HR P20171058T HR P20171058 T1 HRP20171058 T1 HR P20171058T1
Authority
HR
Croatia
Prior art keywords
denotes
compounds according
alkyl
compounds
glutamic acid
Prior art date
Application number
HRP20171058TT
Other languages
English (en)
Croatian (hr)
Inventor
Kurt Puentener
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48430764&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20171058(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20171058T1 publication Critical patent/HRP20171058T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/34—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20171058TT 2012-05-15 2013-05-13 Derivati dipeptida lizinske glutaminske kiseline HRP20171058T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12168119.1A EP2664374A1 (en) 2012-05-15 2012-05-15 Lysin-glutamic acid dipeptide derivatives
EP13722408.5A EP2849882B1 (en) 2012-05-15 2013-05-13 Lysin-glutamic acid dipeptide derivatives
PCT/EP2013/059759 WO2013171135A1 (en) 2012-05-15 2013-05-13 Lysin-glutamic acid dipeptide derivatives

Publications (1)

Publication Number Publication Date
HRP20171058T1 true HRP20171058T1 (hr) 2017-10-06

Family

ID=48430764

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20171058TT HRP20171058T1 (hr) 2012-05-15 2013-05-13 Derivati dipeptida lizinske glutaminske kiseline
HRP20181696TT HRP20181696T1 (hr) 2012-05-15 2018-10-17 Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20181696TT HRP20181696T1 (hr) 2012-05-15 2018-10-17 Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline

Country Status (21)

Country Link
US (3) US9522874B2 (enExample)
EP (3) EP2664374A1 (enExample)
JP (1) JP6162795B2 (enExample)
KR (2) KR102094928B1 (enExample)
CN (1) CN104271227B (enExample)
AR (1) AR091044A1 (enExample)
AU (1) AU2013261894B2 (enExample)
BR (1) BR112014028334B1 (enExample)
CA (2) CA2868144C (enExample)
ES (2) ES2692364T3 (enExample)
HR (2) HRP20171058T1 (enExample)
IL (1) IL235425B (enExample)
MX (2) MX363728B (enExample)
MY (2) MY184184A (enExample)
NZ (1) NZ631215A (enExample)
PL (2) PL2849882T3 (enExample)
RU (1) RU2640812C2 (enExample)
SG (1) SG11201406888QA (enExample)
SI (2) SI3127604T1 (enExample)
WO (1) WO2013171135A1 (enExample)
ZA (1) ZA201407528B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
HUE035803T2 (en) 2012-12-21 2018-05-28 Sanofi Sa Dual GLP1 / GIP or trigonal GLP1 / GIP / glucagon agonists
GB201315335D0 (en) * 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
TW201609797A (zh) 2013-12-13 2016-03-16 賽諾菲公司 雙重glp-1/升糖素受體促效劑
WO2015086730A1 (en) 2013-12-13 2015-06-18 Sanofi Non-acylated exendin-4 peptide analogues
WO2015086728A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
EP3080154B1 (en) 2013-12-13 2018-02-07 Sanofi Dual glp-1/gip receptor agonists
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自exendin-4之雙重glp-1/升糖素受體促效劑
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
TW201706291A (zh) 2015-07-10 2017-02-16 賽諾菲公司 作為選擇性肽雙重glp-1/升糖素受體促效劑之新毒蜥外泌肽(exendin-4)衍生物
JP6991196B2 (ja) 2016-03-23 2022-02-03 バッヘン・ホールディング・アクチエンゲゼルシャフト グルカゴン様ペプチドを製造するための方法
WO2020208409A1 (en) * 2019-04-10 2020-10-15 Dr. Reddy’S Laboratories Limited Improved processes for the preparation of peptide intermediates/modifiers
CN111454180A (zh) * 2020-04-10 2020-07-28 大连阿拉宁生物技术有限公司 一种索马鲁肽侧链中间体及其制备方法
CN113004370B (zh) * 2021-02-09 2022-06-17 宁波绿之健药业有限公司 一种具有缓解高尿酸血症和调节肠道菌群的二肽及其应用
EP4345104B1 (en) 2022-09-30 2024-08-28 Bachem Holding AG Method for preparing liraglutide

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122009000079I2 (de) * 1996-08-30 2011-06-16 Novo Nordisk As Novo Alle Glp-1 derivate
ATE309818T1 (de) * 2000-03-08 2005-12-15 Novo Nordisk As Senkung des serum cholesterols
US20060258580A1 (en) * 2003-05-14 2006-11-16 Regents Of The University Of Michigan Modulators of Nod1 signaling
JP2006233405A (ja) * 2005-08-16 2006-09-07 Asahi Kasei Chemicals Corp 繊維処理剤
IE20060841A1 (en) * 2006-11-21 2008-05-28 Ipsen Mfg Ireland Ltd Boc and fmoc solid phase peptide synthesis
JP2008290987A (ja) * 2007-05-28 2008-12-04 Shiseido Co Ltd Cmc修復剤、毛髪化粧料およびcmc修復方法
JP5127316B2 (ja) * 2007-06-22 2013-01-23 旭化成ケミカルズ株式会社 化学機械研磨用組成物
MA32970B1 (fr) * 2008-12-15 2012-01-02 Zealand Pharma As Analogues du glucagon
JP6054742B2 (ja) * 2009-07-13 2016-12-27 ジーランド ファーマ アクティーゼルスカブ アシル化グルカゴン類似体
JP2011057663A (ja) * 2009-08-11 2011-03-24 Sumitomo Chemical Co Ltd 化合物及びフォトレジスト組成物
CN102286092B (zh) * 2011-09-14 2014-01-01 深圳翰宇药业股份有限公司 利拉鲁肽的固相合成方法
KR20140114845A (ko) * 2011-12-23 2014-09-29 질랜드 파마 에이/에스 글루카곤 유사체

Also Published As

Publication number Publication date
MX363728B (es) 2019-04-01
RU2014148530A (ru) 2016-07-10
EP2849882B1 (en) 2017-06-14
ES2692364T3 (es) 2018-12-03
KR102018160B1 (ko) 2019-09-04
MX349822B (es) 2017-08-15
HK1200753A1 (en) 2015-08-14
RU2640812C2 (ru) 2018-01-12
EP2849882A1 (en) 2015-03-25
PL3127604T3 (pl) 2019-05-31
ES2637415T3 (es) 2017-10-13
CA2868144C (en) 2021-06-29
CN104271227A (zh) 2015-01-07
KR20190057437A (ko) 2019-05-28
US20170057912A1 (en) 2017-03-02
MX2014013505A (es) 2015-02-10
JP6162795B2 (ja) 2017-07-12
ZA201407528B (en) 2016-05-25
JP2015518821A (ja) 2015-07-06
SI3127604T1 (sl) 2018-11-30
AU2013261894A1 (en) 2015-01-22
BR112014028334A2 (pt) 2018-05-29
EP3127604B1 (en) 2018-08-22
IL235425B (en) 2018-07-31
EP2664374A1 (en) 2013-11-20
KR20150008875A (ko) 2015-01-23
MY172395A (en) 2019-11-22
AU2013261894B2 (en) 2017-02-02
MY184184A (en) 2021-03-24
NZ631215A (en) 2016-06-24
CN104271227B (zh) 2016-12-28
SI2849882T1 (sl) 2017-09-29
CA3096624A1 (en) 2013-11-21
US20150073173A1 (en) 2015-03-12
WO2013171135A1 (en) 2013-11-21
KR102094928B1 (ko) 2020-03-31
EP3127604A1 (en) 2017-02-08
US9802886B2 (en) 2017-10-31
BR112014028334B1 (pt) 2020-02-27
SG11201406888QA (en) 2015-01-29
HRP20181696T1 (hr) 2018-12-14
CA3096624C (en) 2022-09-20
US9522874B2 (en) 2016-12-20
US20180029978A1 (en) 2018-02-01
PL2849882T3 (pl) 2017-10-31
CA2868144A1 (en) 2013-11-21
AR091044A1 (es) 2014-12-30

Similar Documents

Publication Publication Date Title
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
EA201071329A1 (ru) Диамидные производные адамантана и их применение
HRP20161103T1 (hr) Kemijski spojevi
EA201700230A1 (ru) Определенные аминопиридины, композиции на их основе и способы их применения
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
EA201690623A1 (ru) Простациклиновые соединения, композиции и способы их использования
EA201001724A1 (ru) Производные изоксазола и их применение в качестве потенциирующих средств для метаботропных глутаматных рецепторов
EA201190320A1 (ru) Гетероциклические сульфонамиды, их применения и фармацевтические композиции
EA201490582A1 (ru) Пирролбензодиазепины и конъюгаты направленного действия
JO3297B1 (ar) تركيبات و طرق لتعديل fxr
MX384800B (es) Derivado de 3-desoxi y composiciones farmaceuticas del mismo.
BR112015021983A8 (pt) compostos heterocíclicos, composições e usos dos mesmos
ME02800B (me) Nova triciklična jedinjenja
EA201201377A1 (ru) Определенные аминопиридазины, композиции на их основе и способы их использования
EA201101026A1 (ru) Ингибиторы бета-секретазы
PE20191302A1 (es) Composiciones herbicidas que comprenden acido 4-amino-3-cloro-5-fluoro-6-(4-cloro-2-fluoro-3-metoxifenil) piridina-2-carboxilico o un derivado del mismo y sulfonamidas de triazolopirimidina
TN2018000106A1 (en) Farnesoid x receptor modulators
EA201290632A1 (ru) Производные бетулина
CR20140134A (es) Composiciones farmacéuticas
EA201891804A1 (ru) Тетрациклиновые соединения
AR094790A1 (es) Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep
EA201690072A1 (ru) Состав, содержащий гиполипидемическое средство
EA201700504A1 (ru) 5-ароматическое алкинилзамещенное бензомидное соединение и способ его получения, фармацевтическая композиция и их применение
EA201170222A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТРИАЗОЛО[4,3-a]ПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ СРЕДСТВ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И НОВОЕ ПРИМЕНЕНИЕ, В ЧАСТНОСТИ, В КАЧЕСТВЕ ИНГИБИТОРОВ МЕТ
MY184184A (en) Lysin glutamic acid dipeptide derivatives